Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17296589rdf:typepubmed:Citationlld:pubmed
pubmed-article:17296589lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:17296589lifeskim:mentionsumls-concept:C0150369lld:lifeskim
pubmed-article:17296589lifeskim:mentionsumls-concept:C0026764lld:lifeskim
pubmed-article:17296589lifeskim:mentionsumls-concept:C0229671lld:lifeskim
pubmed-article:17296589lifeskim:mentionsumls-concept:C1504389lld:lifeskim
pubmed-article:17296589lifeskim:mentionsumls-concept:C0205160lld:lifeskim
pubmed-article:17296589lifeskim:mentionsumls-concept:C0430292lld:lifeskim
pubmed-article:17296589lifeskim:mentionsumls-concept:C0806492lld:lifeskim
pubmed-article:17296589lifeskim:mentionsumls-concept:C1515895lld:lifeskim
pubmed-article:17296589pubmed:issue2lld:pubmed
pubmed-article:17296589pubmed:dateCreated2007-2-13lld:pubmed
pubmed-article:17296589pubmed:abstractTextMonitoring of serum free immunoglobulin light chains (FLC) in 26 myeloma patients who achieved immunofixation negativity after allografting showed a decrease of FLC at a median of 128 days before immunofixation negativity. In patients who subsequently relapsed, a 25% increase of FLC was observed at a median of 98 days before immunofixation positivity.lld:pubmed
pubmed-article:17296589pubmed:languageenglld:pubmed
pubmed-article:17296589pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17296589pubmed:citationSubsetIMlld:pubmed
pubmed-article:17296589pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17296589pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17296589pubmed:statusMEDLINElld:pubmed
pubmed-article:17296589pubmed:monthFeblld:pubmed
pubmed-article:17296589pubmed:issn1592-8721lld:pubmed
pubmed-article:17296589pubmed:authorpubmed-author:KrögerNicolau...lld:pubmed
pubmed-article:17296589pubmed:authorpubmed-author:ZanderAxel...lld:pubmed
pubmed-article:17296589pubmed:authorpubmed-author:AyukFrancisFlld:pubmed
pubmed-article:17296589pubmed:authorpubmed-author:LioznovMichae...lld:pubmed
pubmed-article:17296589pubmed:authorpubmed-author:SchiederHeike...lld:pubmed
pubmed-article:17296589pubmed:authorpubmed-author:MösbauerUlrik...lld:pubmed
pubmed-article:17296589pubmed:issnTypeElectroniclld:pubmed
pubmed-article:17296589pubmed:volume92lld:pubmed
pubmed-article:17296589pubmed:ownerNLMlld:pubmed
pubmed-article:17296589pubmed:authorsCompleteYlld:pubmed
pubmed-article:17296589pubmed:pagination275-6lld:pubmed
pubmed-article:17296589pubmed:meshHeadingpubmed-meshheading:17296589...lld:pubmed
pubmed-article:17296589pubmed:meshHeadingpubmed-meshheading:17296589...lld:pubmed
pubmed-article:17296589pubmed:meshHeadingpubmed-meshheading:17296589...lld:pubmed
pubmed-article:17296589pubmed:meshHeadingpubmed-meshheading:17296589...lld:pubmed
pubmed-article:17296589pubmed:meshHeadingpubmed-meshheading:17296589...lld:pubmed
pubmed-article:17296589pubmed:meshHeadingpubmed-meshheading:17296589...lld:pubmed
pubmed-article:17296589pubmed:meshHeadingpubmed-meshheading:17296589...lld:pubmed
pubmed-article:17296589pubmed:meshHeadingpubmed-meshheading:17296589...lld:pubmed
pubmed-article:17296589pubmed:meshHeadingpubmed-meshheading:17296589...lld:pubmed
pubmed-article:17296589pubmed:meshHeadingpubmed-meshheading:17296589...lld:pubmed
pubmed-article:17296589pubmed:meshHeadingpubmed-meshheading:17296589...lld:pubmed
pubmed-article:17296589pubmed:meshHeadingpubmed-meshheading:17296589...lld:pubmed
pubmed-article:17296589pubmed:meshHeadingpubmed-meshheading:17296589...lld:pubmed
pubmed-article:17296589pubmed:meshHeadingpubmed-meshheading:17296589...lld:pubmed
pubmed-article:17296589pubmed:year2007lld:pubmed
pubmed-article:17296589pubmed:articleTitleMonitoring serum free light chains in patients with multiple myeloma who achieved negative immunofixation after allogeneic stem cell transplantation.lld:pubmed
pubmed-article:17296589pubmed:publicationTypeLetterlld:pubmed
pubmed-article:17296589pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed